CBD and delta-9 THC are not the same thing. They are two distinct compounds found in the cannabis plant that produce very different effects in your body. Delta-9 THC is the compound responsible for the “high” associated with marijuana, while CBD is non-intoxicating and won’t alter your mental state. Despite both coming from the same plant, they interact with your brain in nearly opposite ways.
How CBD and Delta-9 THC Differ
Both CBD (cannabidiol) and delta-9 THC (tetrahydrocannabinol) are cannabinoids, meaning they’re naturally occurring compounds in cannabis. They even share a similar molecular structure. But a small difference in how their atoms are arranged changes everything about how they affect you.
Delta-9 THC directly activates the brain’s primary cannabinoid receptor (CB1) with high potency, binding to it at concentrations as low as about 30 nanomolar. This activation is what produces euphoria, altered perception, impaired coordination, increased appetite, and sometimes anxiety or paranoia. CBD, by contrast, binds very poorly to that same receptor. In lab studies, CBD requires roughly 1,000 times higher concentrations to interact with the receptor’s main binding site compared to THC. That’s why CBD doesn’t get you high.
What CBD does instead is more subtle. Rather than activating the receptor directly, it acts as a kind of dimmer switch, changing the receptor’s shape slightly so that THC and even your body’s own cannabinoid-like molecules are less effective at activating it. In cell studies, CBD reduced both the strength and effectiveness of THC’s signaling in neurons.
Why One Gets You High and the Other Doesn’t
The high from delta-9 THC comes specifically from its activation of CB1 receptors in the brain. When THC locks onto these receptors, it reduces the release of several key signaling chemicals between neurons, including glutamate, GABA, and acetylcholine. This disruption in normal brain communication is what creates the psychoactive experience: altered time perception, heightened sensory input, relaxation, or in some cases anxiety and paranoid thinking.
CBD doesn’t trigger any of that. Because it doesn’t activate CB1 receptors in the same way, it doesn’t disrupt normal neurotransmitter release or produce a subjective high. In fact, when researchers give people CBD before administering THC intravenously, CBD blocks some of THC’s more unpleasant effects. In one study, three out of six participants developed psychotic symptoms after receiving THC alone. When those same participants were pretreated with CBD, those symptoms were significantly reduced. CBD also appears to lower the anxiety and paranoia that THC can cause.
Where Each Compound Comes From
Both CBD and delta-9 THC come from the cannabis plant, but the plant’s genetics determine which compound dominates. Marijuana varieties carry genes that produce high levels of THC, while hemp varieties carry a different version of that gene that instead channels production toward CBD. Hemp plants also show significantly lower overall activity in the cannabinoid-producing pathways compared to marijuana.
Under U.S. federal law, the distinction is drawn at a specific threshold. The 2018 Farm Bill defines hemp as cannabis containing no more than 0.3% delta-9 THC on a dry-weight basis. Anything above that concentration is legally classified as marijuana. This means most CBD products on the market are derived from hemp and contain only trace amounts of THC, though “trace” doesn’t always mean zero.
CBD Products Can Still Contain Delta-9 THC
This is where things get tricky for consumers. Full-spectrum CBD products are made from whole hemp extract, which legally can contain up to 0.3% delta-9 THC. That small amount can add up depending on how much you use and how concentrated the product is.
A Johns Hopkins study tested what happens when people vape cannabis with a CBD-to-THC ratio of 27 to 1, similar to what you’d find in legal hemp products. Each session delivered about 100 milligrams of CBD and just 3.7 milligrams of THC. Despite the tiny THC dose, two out of six participants tested positive on a standard urine drug screen using the same 50 nanograms-per-milliliter cutoff that employers and criminal justice programs use. If you’re subject to drug testing, even legal CBD products carry some risk of triggering a positive result.
Broad-spectrum CBD products and CBD isolates are processed to remove THC entirely, though manufacturing isn’t always perfect. If passing a drug test matters to you, isolate-based products are the safer bet.
FDA-Approved Uses for Each
The FDA has approved medications containing each compound, but for different conditions. Epidiolex, a purified CBD drug, is approved to treat seizures in patients one year and older with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. It’s the only FDA-approved drug containing a compound derived directly from cannabis.
On the THC side, the FDA has approved synthetic versions of delta-9 THC (sold as Marinol and Syndros) primarily for treating the severe appetite loss and weight loss associated with AIDS. A related synthetic compound with a similar chemical structure to THC (Cesamet) is also approved. These are all prescription medications, not the gummies or tinctures sold at dispensaries or gas stations.
The Legal Landscape Is Shifting
The 0.3% THC rule from the 2018 Farm Bill created an enormous market for hemp-derived products, including edibles and beverages that contain delta-9 THC extracted from hemp. Because the law measures THC concentration by dry weight, manufacturers can add meaningful doses of THC to a heavy product like a gummy or drink and still technically stay under the 0.3% threshold. Some states, like Georgia, allowed products with up to 10 milligrams of THC per serving.
That loophole is closing. Recent federal legislation introduced a new limit of just 0.4 milligrams of THC per container for hemp products, a change that would effectively ban most hemp-derived THC edibles and, according to industry groups, over 95% of existing hemp extract products on the market, including many non-intoxicating CBD products. State laws vary widely, so the legality of any hemp-derived product depends heavily on where you live and when you’re buying it.
How CBD and THC Interact Together
Many cannabis products contain both CBD and delta-9 THC, and the two compounds don’t simply stack their effects. CBD actively modulates THC’s impact on the brain. In cell-based studies, CBD reduced THC’s ability to activate cannabinoid receptors and blocked certain forms of synaptic signaling that THC normally triggers. In human studies, CBD pretreatment significantly lowered the psychotic symptoms, paranoia, and anxiety that THC caused on its own.
This is one reason cannabis strains or products with balanced CBD-to-THC ratios tend to produce a milder, less anxiety-prone experience than high-THC products with little CBD. If you’re choosing cannabis products and are sensitive to THC’s side effects, a higher CBD ratio may help take the edge off, though the exact mechanism is still being studied in real-world conditions.